Literature DB >> 27187040

X-Chromosome Inactivation Analysis in Different Cell Types and Induced Pluripotent Stem Cells Elucidates the Disease Mechanism in a Rare Case of Mucopolysaccharidosis Type II in a Female.

M Řeboun1, J Rybová1, R Dobrovolný1, J Včelák1, T Veselková1, G Štorkánová1, D Mušálková1, M Hřebíček1, J Ledvinová1, M Magner2, J Zeman2, K Pešková1, L Dvořáková1.   

Abstract

Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder resulting from deficiency of iduronate-2-sulphatase activity. The disease manifests almost exclusively in males; only 16 symptomatic heterozygote girls have been reported so far. We describe the results of X-chromosome inactivation analysis in a 5-year-old girl with clinically severe disease and heterozygous mutation p.Arg468Gln in the IDS gene. X inactivation analysed at three X-chromosome loci showed extreme skewing (96/4 to 99/1) in two patient's cell types. This finding correlated with exclusive expression of the mutated allele. Induced pluripotent stem cells (iPSC) generated from the patient's peripheral blood demonstrated characteristic pluripotency markers, deficiency of enzyme activity, and mutation in the IDS gene. These cells were capable of differentiation into other cell types (cardiomyocytes, neurons). In MPS II iPSC clones, the X inactivation ratio remained highly skewed in culture conditions that led to partial X inactivation reset in Fabry disease iPSC clones. Our data, in accordance with the literature, suggest that extremely skewed X inactivation favouring the mutated allele is a crucial condition for manifestation of MPS II in females. This suggests that the X inactivation status and enzyme activity have a prognostic value and should be used to evaluate MPS II in females. For the first time, we show generation of iPSC from a symptomatic MPS II female patient that can serve as a cellular model for further research of the pathogenesis and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27187040

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  9 in total

Review 1.  Modeling neuronopathic storage diseases with patient-derived culture systems.

Authors:  Friederike Zunke; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2019-02-19       Impact factor: 5.996

Review 2.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

3.  Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies.

Authors:  Noriko Watanabe; Kohei Kitada; Katherine E Santostefano; Airi Yokoyama; Sara M Waldrop; Coy D Heldermon; Daisuke Tachibana; Masayasu Koyama; Amy M Meacham; Christina A Pacak; Naohiro Terada
Journal:  Cell Reprogram       Date:  2020-06-30       Impact factor: 1.987

Review 4.  Dosage Compensation in Females with X-Linked Metabolic Disorders.

Authors:  Patrycja Juchniewicz; Ewa Piotrowska; Anna Kloska; Magdalena Podlacha; Jagoda Mantej; Grzegorz Węgrzyn; Stefan Tukaj; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 5.  Induced pluripotent stem cell models of lysosomal storage disorders.

Authors:  Daniel K Borger; Benjamin McMahon; Tamanna Roshan Lal; Jenny Serra-Vinardell; Elma Aflaki; Ellen Sidransky
Journal:  Dis Model Mech       Date:  2017-06-01       Impact factor: 5.758

6.  IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing.

Authors:  Kristyna Brejchova; Lubica Dudakova; Pavlina Skalicka; Robert Dobrovolny; Petr Masek; Martina Putzova; Mariya Moosajee; Stephen J Tuft; Alice E Davidson; Petra Liskova
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-07-01       Impact factor: 4.799

7.  Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.

Authors:  Yuki Morimoto; Kazuhisa Chonabayashi; Hiroshi Kawabata; Chikako Okubo; Makiko Yamasaki-Morita; Misato Nishikawa; Megumi Narita; Azusa Inagaki; Kayoko Nakanishi; Miki Nagao; Akifumi Takaori-Kondo; Yoshinori Yoshida
Journal:  Blood Adv       Date:  2022-02-22

8.  The enzymatic de-epithelialization technique determines denuded amniotic membrane integrity and viability of harvested epithelial cells.

Authors:  Peter Trosan; Ingrida Smeringaiova; Kristyna Brejchova; Jan Bednar; Oldrich Benada; Olga Kofronova; Katerina Jirsova
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

9.  Effect of Exogenous Transcription Factors Integration Sites on Safety and Pluripotency of Induced Pluripotent Stem Cells.

Authors:  S Yin; W Li; G Yang; Y Cheng; Q Yi; S Fan; Q Ma; F Zeng
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.